Sooma's newest system makes neurostimulation for depression accessible, cost-effective and available for home use.
HELSINKI, Oct. 26, 2023 /PRNewswire/ -- Sooma Medical, a leading non-invasive neuromodulation company, announces the launch of its new system for the remote treatment of depression, Sooma Duo. Comprised of a medical device, a treatment management platform and a patient app, the system brings remote monitoring and patient guidance to neuromodulation, enabling medication-free depression treatments for patients who cannot access traditional services in the clinic and thus promoting equitable access to treatment for all patients.
Depression is the most common mental health condition among the general population, affecting more than 300 million people worldwide, according to the WHO*. Furthermore, it is estimated that 50% of those suffering from depression will not receive adequate treatment. Sooma's innovative new system is designed to expand access to depression treatment by providing clinicians with a drug-free therapeutic option that patients can safely self-administer in their own homes. This allows neuromodulation treatments to be prescribed similarly to traditional antidepressants, making them more accessible and cost-effective.
To read more about Sooma Duo, visit: www.soomamedical.com/duo/
"Depression is the leading cause of disability in modern society. However, patients often do not have timely access to effective treatment," said Tuomas Neuvonen, CEO of Sooma. "Duo represents a significant step forward in making depression treatment more accessible by providing healthcare professionals with a versatile tool to combat this epidemic."
Sooma Duo is based on transcranial direct current stimulation (tDCS), a recognized and effective depression treatment. Unlike other neuromodulation therapies for this condition, which require a healthcare professional to treat patients individually with a clinical device, Sooma Duo provides doctors with the ability to care for many patients at once while monitoring remotely. the benefits and compliance of treatment.
Sooma Duo is MDR certified and is now available to doctors across Europe, with more markets coming soon.
Sooma Medical is a leading medical device company specializing in non-invasive neuromodulation. Sooma devices have been validated through clinical trials and have treated more than 17,000 patients. www.soomamedical.com
Contact:Irene Molinairene@soomamedical.com 358449716396
Photo - https://mma.prnewswire.com/media/2254601...
View original content: https://www.prnewswire.com/es/comunicados-de-prensa/sooma-lanza-un-sistema-para-estimulacion-cerebral-remota-controlada-por-un-medico-301966142.html